Recent Perspectives of Nanovaccines

Sophia Inbaraj

International journal of Nanobiotechnology

Recent Perspectives of Nanovaccines

Sophia Inbaraj

Abstract

Vaccines are the whole or partial component of the infectious organism which are injected into host to stimulate immune response against the disease. The traditional vaccines suffer limitations such as conversion to virulence, lack of desired immune response, adverse reactions etc. In the recent decades, nanomaterial-based vaccines were found to be safe and better immunogens than traditional ones. Nanovaccines target the antigen presenting cells and hence able to induce humoral, mucosal and cell mediated immune response. The mucosal immunity offered by nanovaccines makes it an attractive candidate for mucosal route of delivery which favours mass immunisation. Therefore, more research in the field will further help in commercial production and use of nanovaccine.

Full text

The full text of this article is available to subscribers.

On a subscribing campus you are let in by network address, with no login at all.

One-off purchase. Permanent access to this article, no account needed.

A year of online access to every article in International journal of Nanobiotechnology. Or choose several journals →

Article details

Recent Perspectives of Nanovaccines

Abstract

Read more of it

Publish your article

Abstract

Related articles

Intelligent Nanobots: Real-Time Framework for Molecular Pollution Detection and Health Risk Mitigation

An investigation into the use of nanotechnology in medical-military applications

An Overview on Nanomaterial-Enabled Electronic Skin for Physiological Sensing and Biomedical Use

Nanobiotechnology in the Real World: How Lab Ideas Affect Real Life

Enhancing the strength and flexibility of crowns and bridges: advances in materials, design, and nanotechnology.

Xerostomia and Salivary Gland Hypofunction: From Pathophysiology to Nanotechnology‑Enabled Regenerative Therapies

Read more of it

Publish your article